tablet-yellow

Droperidol (Inapsine)

Anesthesia Implications

Clinically reviewed by anesthesia providers · Updated

Classification:
Butyrophenone; dopamine D2 receptor antagonist
Therapeutic Effects:
Antiemetic, sedation, anxiolysis, antipsychotic
Primary Considerations:

Potent antiemetic - widely used for PONV prophylaxis and treatment at low doses (0.625–1.25 mg IV); highly effective and cost-efficient. QTc Prolongation - The FDA issued a black box warning in 2001...

Continue reading

Read the full drug post with a free account

Free. It opens every drug, surgery and condition in the library.

Already have an account?